drug notes: incretin drugs Flashcards

1
Q

what is an OGTT?

A

oral glucose tolerance test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the incretin effect?

A

-if same amount of glucose is administered orally and on a separate occasion through IV then there will always be more insulin produced the time it has been given orally, suggesting there must be a substance in the gut which acts to increase insulin in the beta cell

(these substances in the gut are called incretins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

True or False

Incretin effect is lost later on in T2DM

A

False- incretin effect is lost earlier on in T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the two incretins?

A

GIP

GLP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what cells secrete GIP?

A

K cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what cells secrete GLP-1?

A

L cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what enzyme breaks down GIP and GLP-1?

A

DPP-IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the half life like for GIP and GLP-1?

A

very short half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are GIP and GLP-1 broken down into and what clears then?

A

they are broken down by DPP-IV into inactive metabolites and then cleared by the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do incretins amplify insulin secretion?

A

-GLP-1 binds to receptot on pancreatic beta cell which increases cAMP and amplifies the release of insulin

however this cannot be done unless the regular triggering for insulin has occured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what pathway do incretins affect?

A

the amplifying pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what affect does increase in cAMP from incretins have on beta pancreatic cell?

A
  • close KATP channel (PKA)
  • modulate calcium currents (PKA)
  • directly on insulin secretory mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what affect does GLP-1 have?

A
  • increase insulin secretion
  • decreases glucagon secretion
  • increases insulin biosynthesis
  • increases beta cell proliferation
  • decreases beta cell apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

whats another name for DPP4 inhibitors?

A

gliptins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the mechanism of action of DPP4 inhibitors (aka Gliptins)?

A

they inhibit DPP4 and so increase the half life of GIP and GLP-1, increasing incretin effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what do DPP4q (gliptins have in common with sulphonylureas?

A

they are insulin secretagogues

17
Q

can DPP4is cause hypoglycaemia?

A

no due to incretin being glucose dependant

18
Q

what affect to DPP4i have on weight?

A

no effect

19
Q

what are side effects of DPP4i?

A
  • generally very well tolerated
  • increased risk in pancreatitis
  • some signal for increased HF hospitalisation
20
Q

are DPP4i’s expensive?

A

yes very!!

21
Q

what is the mechanism of action of GLP-1RA?

A
  • they are GLP-1 like molecules modified to avoid breakdown by DPP4. They act directly on the GLP-1 receptor.
  • they act to promote insulin secretion (insulin secretagogues) in a glucose dependant mechanism and lower glucagon
  • act in other tissues especially hypothalamus to reduce apetite and intestines to reduce gastric emptying
22
Q

are GLP-1RA expensive?

A

yes very!

23
Q

what are side effects of GLP-1RA?

A
  • nausea and vomiting (often improves after 6 weeks)
  • small increase in gallstones
  • small increase in pancreatitis
24
Q

what effect does GLP-1RA have on CV health?

A

improves!

25
Q

when would GLP-1RA be given?

A
  • second line to metformin and high risk cardiovascular disease such as patients who have had a heart attack) (patient will be on metformin and GLP-1RA)
  • if a patient has heart failure or chronic kidney disease and SGLT2i are contraindicated then give GLP-1RA second line the metformin!
26
Q

what should be given to a patient with T2B with no prior disease, CVD, HF or CKD, have already tried metformin and needs to minimize hypoglycaemia?

A

DPP-4i
GLP-1RA
SGLT2i
TZD

27
Q

what should be given to a patient with T2B with no prior disease, CVD, HF or CKD, have already tried metformin and needs to lose weight?

A

GLP-1RA really good for weight loss

-SGLT2i